N-ethylidene-tert-butylamine | 129292-63-3

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: N-ethylidene-tert-butylamine
• 英文别名: N-ethenyl-2-methylpropan-2-amine
• CAS: 129292-63-3
• 化学式: C₆H₁₃N
• 分子量: 99.1759
• InChiKey: LGJRTURUUIZFIN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  7
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  三氟乙酸乙酯 、 N-ethylidene-tert-butylamine 在 正丁基锂 、 二异丙胺 作用下， 生成 4-(tert-butylamino)-1,1,1-trifluorobut-3-en-2-one
  参考文献：
  名称：

  苯胺中的2-（三氟甲基）喹啉：异构化和环化的新模式

  摘要：

  N-亚乙基-叔丁胺用二异丙基氨基锂去质子化，然后与三氟乙酸乙酯缩合，得到4-叔丁基氨基-1,1,1-三氟丁-3-烯-2-酮。当在弱酸性条件下用苯胺处理后一化合物时，会发生氨基取代基的交换。当在三氯化磷的存在下加热时，所得的4-苯胺基-1,1,1-三氟丁-3-烯-2-酮经过侧链的N →邻位移位，然后环化和脱水，得到2-（三氟甲基）喹啉。

  DOI：

  10.1016/0040-4020(96)00168-8
• 作为产物：
  描述：

  乙醛 、 叔丁胺 以 正戊烷 为溶剂， 以63%的产率得到N-ethylidene-tert-butylamine
  参考文献：
  名称：

  Aromatic Quinolinecarboxamides as Selective, Orally Active Antibody Production Inhibitors for Prevention of Acute Xenograft Rejection

  摘要：

  The prevention of xenograft rejection is substantially dependent on inhibiting antibodies (Ab) produced by B-cells independently of T-cell signals (TI-1). Due to their ubiquitous biochemical mechanisms of action, the immunosuppressants currently employed not only fail to discriminate between B- and T-cells but also have a narrow therapeutic window and, thus, their prolonged use in complex immunosuppressive regimens is problematic. By capitalizing on the target enzyme-bound (DHODH) structure Ib of one of these compounds, leflunomide, and modulating part of its multiple mechanisms of action to gain selectivity, the quinoline-8-carboxamide 3 was designed as a potentially weak enzyme inhibitor but effective immunosuppressant. Compound 3 fulfilled the mechanistic criteria set and had 10-fold B-cell over T-cell selectivity. Its pyridyl analogue 4 was found to be a highly potent and selective B-cell immunosuppressant with a 75-fold selectivity for B- over T-cells las judged by the MLR data) and no general cytotoxicity at concentrations up to 160-fold higher than those required to inhibit B-cells. In the mouse, 4 effectively blocked TI-1 Ab production and suppressed Ab-mediated xenograft rejection in a xenotransplantation model under a once-daily dosing regimen, with efficacy down to 0.3 mg/kg/day po. These are the first data demonstrating the feasibility of the development of drugs specific for impeding Ah production.

  DOI：

  10.1021/jm010822m

文献信息

• AHLBRECHT H.; VON DAACKE A., SYNTHESIS,(1987) N 1, 24-28
  作者：AHLBRECHT H.、 VON DAACKE A.

  DOI：——

  日期：——
• Aromatic Quinolinecarboxamides as Selective, Orally Active Antibody Production Inhibitors for Prevention of Acute Xenograft Rejection
  作者：Christos Papageorgiou、Anette von Matt、Joanne Joergensen、Elsebeth Andersen、Katrin Wagner、Christian Beerli、Thai Than、Xaver Borer、Andrea Florineth、Gretty Rihs、Max H. Schreier、Gisbert Weckbecker、Christoph Heusser

  DOI：10.1021/jm010822m

  日期：2001.6.1

  The prevention of xenograft rejection is substantially dependent on inhibiting antibodies (Ab) produced by B-cells independently of T-cell signals (TI-1). Due to their ubiquitous biochemical mechanisms of action, the immunosuppressants currently employed not only fail to discriminate between B- and T-cells but also have a narrow therapeutic window and, thus, their prolonged use in complex immunosuppressive regimens is problematic. By capitalizing on the target enzyme-bound (DHODH) structure Ib of one of these compounds, leflunomide, and modulating part of its multiple mechanisms of action to gain selectivity, the quinoline-8-carboxamide 3 was designed as a potentially weak enzyme inhibitor but effective immunosuppressant. Compound 3 fulfilled the mechanistic criteria set and had 10-fold B-cell over T-cell selectivity. Its pyridyl analogue 4 was found to be a highly potent and selective B-cell immunosuppressant with a 75-fold selectivity for B- over T-cells las judged by the MLR data) and no general cytotoxicity at concentrations up to 160-fold higher than those required to inhibit B-cells. In the mouse, 4 effectively blocked TI-1 Ab production and suppressed Ab-mediated xenograft rejection in a xenotransplantation model under a once-daily dosing regimen, with efficacy down to 0.3 mg/kg/day po. These are the first data demonstrating the feasibility of the development of drugs specific for impeding Ah production.
• 2-(Trifluoromethyl)quinolines from anilines: A novel mode of isomerization and cyclization
  作者：Holger Keller、Manfred Schlosser

  DOI：10.1016/0040-4020(96)00168-8

  日期：1996.3

  in the presence of phosphoryl trichloride, the resulting 4-anilino-1,1,1-trifluorobut-3-en-2-ones undergo an N → ortho shift of the side chain followed by cyclization and dehydration to afford 2-(trifluoromethyl)quinolines.

  N-亚乙基-叔丁胺用二异丙基氨基锂去质子化，然后与三氟乙酸乙酯缩合，得到4-叔丁基氨基-1,1,1-三氟丁-3-烯-2-酮。当在弱酸性条件下用苯胺处理后一化合物时，会发生氨基取代基的交换。当在三氯化磷的存在下加热时，所得的4-苯胺基-1,1,1-三氟丁-3-烯-2-酮经过侧链的N →邻位移位，然后环化和脱水，得到2-（三氟甲基）喹啉。